Genitourinary Surgical Consultants is owned by Dr. Jeffrey A. Snyder, who acts as investigator for various clinical trials. The research department is conveniently located within the clinical office of Dr. Jeffrey A. Snyder.
The clinical department shares patient names with the research department and as a patient of Genitourinary Surgical Consultants you may receive periodic information from our research department about studies which may be of interest to you and/or that your physician has recommended.
Why are Clinical Studies important to Genitourinary Surgical Consultants?
Being involved in research programs helps our office meet its' mission to serve women and men who want to remain active and youthful by empowering them to regain control over their urinary, pelvic and sexual health. Through this association, we are able to offer a wide variety of treatment options and remain on the cutting edge of technology.
What is a Clinical Study?
A Clinical Study is designed to test the effects of a medication, medical treatment or device on a group of volunteers. A group of professionals called the Institutional Review Board or IBR carefully review study activities and is responsible for the safety and well-being of the study volunteers.
Who can be in a Clinical Study?
People with the condition being studied as well as healthy people can volunteer to participate in clinical studies. Each study has specific requirements for participants. The Principle Investigator conducting the study will review the volunteer's medical history and study requirements to determine eligibility. Study procedures, benefits and known risks will be explained to the volunteer prior to participating in the study. This discussion is called the Informed Consent.
What are the benefits of volunteering?
Several benefits exist for the volunteer. These include:
Currently, we are looking for patients to be involved with these studies:
If you have any of these conditions, you may be eligible to participate in a clinical trial. If you're interested in being screened, please contact 303.320.0120.